While some of the 70 HKGs (e.g., PSMD2) have been identified by other genome-wide association studies as relevant in single subtypes of lung cancer development (AD), many have not been fully examined, adding to the list of possible targets for therapeutic development (Matsuyama et al., 2011). The gene discussed is PSMD2; the disease is lung cancer.